English
Français
Português
العربية
Kiswahili
አማርኛ
isiZulu
Yorùbá
Hausa
Igbo
Soomaali
Web Page
AMA Treaty (Official AU Page)
Access →
PDF
AMA Status List (PDF – signatures/ratifications)
Access →
PDF
AMA Treaty – French (PDF)
Access →
PDF
AMA Treaty (PDF – English)
Access →
PDF
AMA Infographic (English)
Access →
PDF
AMA Treaty – Arabic (PDF)
Access →
Press Release
AMA Treaty Entry into Force (Press Release)
Access →
PDF
AMA Infographic (English – alternate AU copy)
Access →
PDF
AMA Treaty – Portuguese (PDF)
Access →
Web Page
AMA FAQs
Access →
Web Page
AU AMA Infographics landing page
Access →
PDF
AMA Institutional Framework
Access →
PDF
AMA Business Plan (Draft)
Access →
PDF
AMA Legal Framework
Access →
Web Page
EMA–AMA Cooperation Overview
Access →
PDF
AMA Treaty (PDF – French)
Access →
PDF
AMA Treaty (PDF – Arabic)
Access →
PDF
AMA Treaty (PDF – Portuguese)
Access →
PDF
AMA Infographic (French)
Access →
Guidelines
IMDRF: Principles of Labelling for Medical Devices & IVDs (Edition 2, 2024)
Access →
Web Page
AU Model Law – Overview Page
Access →
PDF
AU Model Law on Medical Products Regulation – French
Access →
PDF
AU Model Law (PDF)
Access →
PDF
AU Model Law on Medical Products Regulation – Arabic
Access →
PDF
AU Model Law (Annotated Copy)
Access →
PDF
AU Model Law on Medical Products Regulation – Portuguese
Access →
PDF
PATH Policy Brief on AU Model Law
Access →
Web Page
East African Community (EAC-MRH) - Documents
Access →
Web Page
EAC-MRH Document Repository (category page)
Access →
PDF
ECOWAS Regional Pharmaceutical Plan (ERPP) (PDF)
Access →
Guidelines
ZaZiBoNa Guidelines index
Access →
Guidelines
EAC Medicines Regulatory Guidelines
Access →
Guidelines
EAC Medicines Regulatory Guidelines (index page)
Access →
Guidelines
ZaZiBoNa GMP Guidelines (page)
Access →
PDF
ECOWAS/WAHO - Regional Joint Medicines Assessment Procedure
Access →
PDF
EAC Joint Regulatory Procedures Brochure (PDF, June 2020)
Access →
Web Page
ZaZiBoNa FAQs
Access →
PDF
ECOWAS Joint Assessment Procedure (Edited)
Access →
Web Page
EAC MRH Programme page (includes PV/APIMF tool links)
Access →
Web Page
ZaZiBoNa National Registers (index)
Access →
Portal
ZaZiBoNa Initiative
Access →
Report
EAC Repository Annual Report 2018–2019
Access →
Web Page
ZaZiBoNa home/centralised submission notice
Access →
Web Page
About ZaZiBoNa
Access →
PDF
Early EAC MRH progress deck (guideline development overview)
Access →
PDF
ZaZiBoNa presentation (SAHPRA-hosted PDF)
Access →
Web Page
SADC - Quality Assured Medicines
Access →
Web Page
Africa Medical Devices Forum (AMDF)
Access →
Web Page
AMDF Technical Committee
Access →
Report
WHO Africa – AMDF COVID-19 Report
Access →
PDF
IMDRF–Africa Medical Devices Report
Access →
PDF
AMDF Guideline: Inspection of Manufacturing Sites (French draft)
Access →
PDF
AMDF Guideline: Registration of Medical Device Establishments (English draft)
Access →
PDF
AMDF Guideline: Enregistrement des établissements (French draft)
Access →
PDF
AMDF Guideline: Importation & Exportation of Medical Devices (English draft)
Access →
PDF
AMDF Guideline: Importation/Exportation de dispositifs médicaux (French draft)
Access →
PDF
AMDF: Specific Considerations for Regulating MNCH Medical Devices (Market Authorisation)
Access →
Web Page
AVAREF Overview (WHO AFRO)
Access →
Guidelines
AVAREF Guidelines
Access →
Web Page
AVAREF Technical Committee (AMRH)
Access →
Publication
AVAREF Strategy & Emergency Preparedness
Access →
Web Page
African Medicines Quality Forum (AMQF-TC)
Access →
PDF
AMQF Pharmaceutical Laboratory Equipment Management Guideline (PDF, 2024)
Access →
Web Page
USP PQM+ – AMQF Overview
Access →
Web Page
EDQM–Africa Regulatory Strengthening
Access →
Web Page
WHO Global Benchmarking Tool (GBT)
Access →
Web Page
WHO: Global Benchmarking Tools (GBT) – landing
Access →
Web Page
AVAREF – WHO AFRO Overview (FR/EN)
Access →
Web Page
WHO Regional Work-Sharing & Joint Reviews
Access →
Web Page
WHO: Regional joint activities and work-sharing – landing
Access →
Web Page
WHO Maturity Level 3 Achievements (Africa)
Access →
Web Page
NAFDAC Recalls & Safety Alerts (index page) (2025)
Access →
News Article
NAFDAC Public Alert No. 027/2025 – Counterfeit Postinor2 (Levonorgestrel 0.75mg) (2025)
Access →
News Article
NAFDAC Public Alert No. 21/2025 – Unregistered Tarivid (Ofloxacin 200mg) (2025)
Access →
News Article
NAFDAC Public Alert No. 17/2025 – Falsified Healmoxy Capsules 500mg (2025)
Access →
News Article
NAFDAC Public Alert No. 13/2025 – Counterfeit Accu-Chek Instant Test Strips (2025)
Access →
News Article
NAFDAC Public Alert No. 11/2025 – Recall by Sun Pharma/Glenmark/Zydus (2025)
Access →
News Article
NAFDAC Public Alert No. 010/2025 – Fake “Wonder Calcium” product (2025)
Access →
Press Release
NAFDAC Public Alert No. 09/2025 – Voluntary recall of Zovirax IV infusion (GSK) (2025)
Access →
News Article
NAFDAC Public Alert No. 07/2025 – Falsified OXYCONTIN 80mg (WHO European Region) (2025)
Access →
News Article
NAFDAC Public Alert No. 05/2025 – Falsified Cikatem with falsified NRN (2025)
Access →
Press Release
NAFDAC (Notice) – Blacklisting Aveo + banning Tapentadol/Carisoprodol combinations (2025)
Access →
News Article
NAFDAC Public Alert No. 04/2025 – Illegal exportation/sale of opioids (Aveo) (2025)
Access →
News Article
NAFDAC Public Alert No. 03/2025 – Counterfeit/Falsified Petsow Starnicillin 500mg (2025)
Access →
Press Release
NAFDAC Public Alert No. 01/2025 – Discontinued registration of multi-dose Artemether/Lumefantrine dry powder (2025)
Access →
Press Release
MCAZ – MEDIA RELEASE: Class II Recall of Captopril 25mg Tablets (2025)
Access →
PDF
MCAZ – Notice: Lenacapavir 463.5mg/1.5ml Injection (Sunlenca) (2025)
Access →
Press Release
MCAZ – Warning: Adulterated HONEY with Sildenafil/Tadalafil (2025)
Access →
Press Release
MCAZ – Warning: “Handy Heroes” (adulterated product alert) (2025)
Access →
PDF
MCAZ – MoU: Zambia Medicines Regulatory Authority (ZAMRA) (2025)
Access →
Web Page
TMDA Announcement – Payment of Annual Retention Fees for the Year 2024 (2024)
Access →
Press Release
TMDA Public Notice – Quality testing of Glycerin 99.5% USP at TMDA lab (2022)
Access →
Press Release
TMDA Public Notice – COVID-19 Vaccine Emergency Use Authorization (EUA) (2021)
Access →
Press Release
TMDA Public Notice – Foreign customers for premises: requirements and procedures (2020)
Access →
Press Release
TMDA Public Notice – Tobacco smoking public health warning (2021)
Access →
Press Release
TMDA Public Notice – Shifting of Authority Functions (2019)
Access →
News Article
TMDA Public Notice – Expression of Interest: Evaluators of Medicinal Products and Medical Devices (2024)
Access →
News Article
WHO AFRO – Africa sets course for affordable, quality medicines with new 10-year roadmap (2025)
Access →
News Article
WHO AFRO (Namibia) – Regulatory strengthening through WHO-assisted self-benchmarking (2025)
Access →
News Article
WHO AFRO (Angola) – Strengthening regulation of medicines and health technologies (2025)
Access →
Press Release
African Union – AMA Treaty enters into force (Press Release) (2021)
Access →
News Article
AMRH – Call for industry applications: Pilot of continental listing of medicinal products (2025)
Access →
News Article
AMRH – Call for industry applications: Mpox candidate medicinal products (expedited evaluation) (2025)
Access →
News Article
AMRH – Invitation of Expression of Interest: Mpox diagnostic IVD manufacturers/developers (2025)
Access →
Web Page
WHO – Global Benchmarking Tools (GBT) page (reference used in NRA strengthening news) (ongoing)
Access →
Web Page
TMDA Publications Index – Medicines Registration Guidelines listing (reference point) (ongoing)
Access →
Web Page
ZA Zi Bo Na – Home / notices (regional work-sharing updates) (ongoing)
Access →
Web Page
ZA Zi Bo Na – FAQs (ongoing)
Access →
Web Page
WHO – Regional joint activities and work-sharing (reference) (ongoing)
Access →
Web Page
EAC – MRH programme page (regional collaboration updates) (ongoing)
Access →
Web Page
EAC – EAC-MRH document repository (regional documents/news) (ongoing)
Access →
Web Page
AU – AMA Treaty official page (key reference) (ongoing)
Access →
Web Page
EMA – Cooperation overview with African Medicines Agency (AMA) (reference) (ongoing)
Access →
Web Page
WHO AFRO – Essential medicines topic page (featured news entry point; multi-language) (ongoing)
Access →
Portal
AMRH – Programme portal (news + publications entry point) (ongoing)
Access →
Portal
MCAZ – Portal home (publications/press release entry point) (ongoing)
Access →
Web Page
NAFDAC – Recalls & Safety Alerts category root (ongoing)
Access →
Web Page
TMDA – Announcements index (ongoing)
Access →
Web Page
WHO AFRO – Featured news index (multi-language) (ongoing)
Access →
Web Page
AMRH – Resources page (reference entry point) (ongoing)
Access →
Web Page
ZA Zi Bo Na – Guidelines index (regional technical updates) (ongoing)
Access →
Portal
AMRH Programme Portal
Access →
Publication
Nature – African Medicines Agency Analysis
Access →
Web Page
EMP-TC Continental Procedure (AMRH publication page)
Access →
PDF
Applicants: Biotherapeutic Products (EMP-TC guidance PDF)
Access →
PDF
CTD Product Dossier Guideline (PDF)
Access →
Web Page
PPB Guidelines download portal
Access →
PDF
Marketing Authorisation: Procedural Aspects (Human Pharma) (PDF)
Access →
Web Page
TMDA Medicines Registration Guidelines listing (portal page)
Access →
PDF
SAHPRA GMP Guideline (PDF, 2022)
Access →
Publication
EAC Joint Assessment performance paper (ScienceDirect, 2023)
Access →
PDF
1st Biennial Scientific Conference book of abstracts (PDF)
Access →
PDF
Pharmaceutical Manufacturing Plan for Africa (PMPA) Business Plan (PDF)
Access →
Web Page
AMRH Tanzania profile (PMS/regulatory context)
Access →
Portal
Morocco AMMPS – Official Portal (FR)
Access →
Web Page
AMRH Resource Hub
Access →
Publication
PLOS Global Public Health – AMA Readiness
Access →
PDF
EMP-TC Guidelines on Procedural Aspects for Submission (PDF)
Access →
PDF
Applicants: Biosimilar Products (EMP-TC guidance PDF)
Access →
PDF
CTD Table of Contents (Modules 2–5) (PDF)
Access →
Publication
Compendium: Medicines Evaluation & Registration (PPB)
Access →
PDF
Renewal of Registered Human Pharma Products (PDF)
Access →
PDF
Compendium: Marketing Authorisation of Medicinal Products (PDF, July 2020)
Access →
PDF
MCA (Gambia) – Renewal of Marketing Authorisation Guideline (PDF, 2025)
Access →
PDF
EAC MRH effectiveness/efficiency evaluation (Ngum et al., 2022 PDF)
Access →
Report
2nd Biennial Scientific Conference report (PDF)
Access →
Web Page
AMMPS – New AMM Guidelines Announcement (FR)
Access →
Web Page
Regional Centres of Regulatory Excellence (RCOREs)
Access →
Publication
BMJ Global Health – Regulatory Harmonisation
Access →
Guidelines
Guidance: Eligibility Criteria for Priority Products (AMRH)
Access →
PDF
Brand Names: Guidance for Applicants (EMP-TC PDF)
Access →
PDF
Guidelines: Registration of Drug Products Made in Nigeria (2025 PDF)
Access →
Guidelines
Premises Registration & Licensing Guidelines (PPB)
Access →
PDF
Rwanda medicines registration regulation draft (PDF)
Access →
Web Page
Procedures for Marketing Authorisation (web page)
Access →
Publication
ZaZiBoNa work-sharing analysis (PMC full text, 2025)
Access →
Report
3rd Biennial Scientific Conference report (PDF, 2017)
Access →
Portal
Senegal ARP – Official Portal (FR)
Access →
Publication
RCOREs Overview Publication
Access →
PDF
World Bank – Medicines Regulation in Africa
Access →
PDF
Continental Regulatory Reliance Framework (PDF, 2025)
Access →
PDF
Guidelines: Registration of Imported Drug Products (2025 PDF)
Access →
PDF
PPB Drug registration application form (PDF)
Access →
Web Page
Rwanda FDA enabling law (RwandaLII)
Access →
PDF
Guidelines: Variations on Registered Medicinal Products (PDF)
Access →
Publication
ZaZiBoNa milestone paper (Taylor & Francis, 2025)
Access →
PDF
ARP Senegal – AMM Modalities Guideline (FR PDF)
Access →
Web Page
Call: Pilot of Continental Listing of Medicinal Products (AMRH)
Access →
PDF
Vaccines: CTD Submission Guidance (PDF)
Access →
PDF
PPB Drug registration guideline (PDF copy)
Access →
PDF
Import/Export authorisation regulations (Rwanda FDA file)
Access →
PDF
Guidelines: Labelling Format/Content for Medicinal Products (PDF)
Access →
Publication
ZaZiBoNa effectiveness & efficiency (ResearchGate entry)
Access →
Portal
Côte d’Ivoire AIRP – Official Portal (FR)
Access →
Web Page
Call: Mpox Candidate Medicinal Products – Expedited Evaluation
Access →
PDF
Legacy local registration guideline (PDF)
Access →
PDF
Clinical Trials Guidelines in Kenya (PDF)
Access →
PDF
Guidelines: Import/Export of Pharma Products & Raw Materials (PDF)
Access →
PDF
Evaluating success of ZaZiBoNa (Dissertation/PDF, 2020)
Access →
Web Page
Call: Mpox Diagnostic IVD Manufacturers/Developers (EOI)
Access →
PDF
Kenya health products registration rules (Legal Notice, PDF)
Access →
PDF
Medical Device Registration Guidelines (PDF, 2016)
Access →
Publication
EAC joint assessment procedure paper (ResearchGate record)
Access →
PDF
Medical Devices Regulations (PDF, 2015)
Access →
Publication
TMDA GMP inspections study (PMC full text, 2024)
Access →
PDF
Guidelines: Import/Export of Medical Devices incl. IVDs (PDF, 2020)
Access →
PDF
Compendium: Devices/Diagnostics/Lab Equipment (PDF, June 2024)
Access →
PDF
Ghana FDA: Guideline on Registration of Allopathic Drugs (PDF)
Access →
Web Page
TMDA: Medical Devices marketing authorisation procedures
Access →
Web Page
TMDA: Registration/licensing of premises (web page)
Access →
PDF
TMDA: Regulatory Reliance for Marketing Authorisation (PDF, July 2025)
Access →
PDF
TMDA MAGHP experience (Swissmedic webinar PDF)
Access →
PDF
Zimbabwe MCAZ: Guideline on submission of documentation (CTD Quality) for multisource FPP (PDF)
Access →
PDF
Zambia ZAMRA: CTD Marketing Authorisation Guidance (Quality part) (PDF)
Access →
PDF
Zambia ZAMRA: Guideline on Establishment of a Pharmaceutical Retail Business (Amendment) (PDF)
Access →
Web Page
Malawi PMRA: Guidelines Portal (landing page)
Access →
PDF
Malawi PMRA: Fast Track Registration Guideline (PDF)
Access →
Web Page
Medias24 (FR) – Morocco publishes new medicines guidelines
Access →
Web Page
AP News – African Medicines Agency public health priorities
Access →
Web Page
Le Monde Afrique – Côte d’Ivoire enforcement action (FR)
Access →